Eton Pharmaceuticals, Inc. (ETON) vs Pacira BioSciences, Inc. (PCRX)
- Eton Pharmaceuticals, Inc. ETON 50.40 −1.81%
- Pacira BioSciences, Inc. PCRX 36.35 +0.06%
Eton Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are of similar size ($1.5B and $1.5B). Pacira BioSciences, Inc. trades at the lower P/E: 104× against 107×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 5.71%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs 1.96%) and the higher return on invested capital (21.4% vs 1.58%). Across the 21 metrics below, Pacira BioSciences, Inc. leads on 12 and Eton Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | ETON | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 57.87% | 79.21% | 53.94% |
| Operating margin | 15.44% | 2.66% | 0.00% |
| Net margin | 12.02% | 1.96% | 0.00% |
| Free cash flow margin | (7.94%) | 24.06% | 0.00% |
| Return on equity | 35.97% | 2.05% | (0.40%) |
| Return on assets | 11.67% | 1.05% | (3.32%) |
| Return on invested capital | 21.39% | 1.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack